Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update
Abstract In recent years, the incidence of thyroid cancer has steadily increased. However, the detailed mechanisms of pathogenesis are still unclear. Therefore, a comprehensive understanding of the underlying carcinogenesis mechanisms of thyroid cancer is required. Programmed cell death (PCD) is a c...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-02-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-01815-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823861774908129280 |
|---|---|
| author | Yuejia Zhao Simeng Zhao Zhe Fan Yongfu Zhao Guangzhi Wang |
| author_facet | Yuejia Zhao Simeng Zhao Zhe Fan Yongfu Zhao Guangzhi Wang |
| author_sort | Yuejia Zhao |
| collection | DOAJ |
| description | Abstract In recent years, the incidence of thyroid cancer has steadily increased. However, the detailed mechanisms of pathogenesis are still unclear. Therefore, a comprehensive understanding of the underlying carcinogenesis mechanisms of thyroid cancer is required. Programmed cell death (PCD) is a cell death process mediated by specific molecular program, regulated by specific genes within the cell. Accumulating evidence suggests that PCD plays an indispensable role in thyroid cancer, maintaining intracellular stability by regulating genes and eliminating damaged or aged cells. In this review, we summarize six identified forms of PCD, analyze biomarkers for different PCD pathways in thyroid cancer, and briefly elucidate the roles of various PCD pathways in targeted therapies for thyroid cancers with a poor prognosis. We also provide an outlook on future treatments for drug-resistant thyroid cancer, poorly differentiated thyroid cancer, and iodine-refractory thyroid cancer, aiming to accurately identify targets and offer effective targeted therapeutic strategies. |
| format | Article |
| id | doaj-art-01399e47534e4f1e8906f14b5192a11c |
| institution | Kabale University |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-01399e47534e4f1e8906f14b5192a11c2025-02-09T12:43:31ZengSpringerDiscover Oncology2730-60112025-02-0116111010.1007/s12672-025-01815-wRelationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an updateYuejia Zhao0Simeng Zhao1Zhe Fan2Yongfu Zhao3Guangzhi Wang4Department of General Surgery, The Second Hospital of Dalian Medical UniversityDepartment of General Surgery, The Second Hospital of Dalian Medical UniversityDepartment of General Surgery, The Third People’s Hospital of Dalian, Dalian Medical UniversityDepartment of General Surgery, The Second Hospital of Dalian Medical UniversityDepartment of General Surgery, The Second Hospital of Dalian Medical UniversityAbstract In recent years, the incidence of thyroid cancer has steadily increased. However, the detailed mechanisms of pathogenesis are still unclear. Therefore, a comprehensive understanding of the underlying carcinogenesis mechanisms of thyroid cancer is required. Programmed cell death (PCD) is a cell death process mediated by specific molecular program, regulated by specific genes within the cell. Accumulating evidence suggests that PCD plays an indispensable role in thyroid cancer, maintaining intracellular stability by regulating genes and eliminating damaged or aged cells. In this review, we summarize six identified forms of PCD, analyze biomarkers for different PCD pathways in thyroid cancer, and briefly elucidate the roles of various PCD pathways in targeted therapies for thyroid cancers with a poor prognosis. We also provide an outlook on future treatments for drug-resistant thyroid cancer, poorly differentiated thyroid cancer, and iodine-refractory thyroid cancer, aiming to accurately identify targets and offer effective targeted therapeutic strategies.https://doi.org/10.1007/s12672-025-01815-wProgrammed cell deathThyroid cancerTargeted therapy |
| spellingShingle | Yuejia Zhao Simeng Zhao Zhe Fan Yongfu Zhao Guangzhi Wang Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update Discover Oncology Programmed cell death Thyroid cancer Targeted therapy |
| title | Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update |
| title_full | Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update |
| title_fullStr | Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update |
| title_full_unstemmed | Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update |
| title_short | Relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis: an update |
| title_sort | relationship between programmed cell death and targeted therapy for thyroid cancer in patients with a poor prognosis an update |
| topic | Programmed cell death Thyroid cancer Targeted therapy |
| url | https://doi.org/10.1007/s12672-025-01815-w |
| work_keys_str_mv | AT yuejiazhao relationshipbetweenprogrammedcelldeathandtargetedtherapyforthyroidcancerinpatientswithapoorprognosisanupdate AT simengzhao relationshipbetweenprogrammedcelldeathandtargetedtherapyforthyroidcancerinpatientswithapoorprognosisanupdate AT zhefan relationshipbetweenprogrammedcelldeathandtargetedtherapyforthyroidcancerinpatientswithapoorprognosisanupdate AT yongfuzhao relationshipbetweenprogrammedcelldeathandtargetedtherapyforthyroidcancerinpatientswithapoorprognosisanupdate AT guangzhiwang relationshipbetweenprogrammedcelldeathandtargetedtherapyforthyroidcancerinpatientswithapoorprognosisanupdate |